首页 | 本学科首页   官方微博 | 高级检索  
检索        

胆固醇酯转运蛋白抑制剂的研究进展
引用本文:熊绪琼,赵冬梅,程卯生.胆固醇酯转运蛋白抑制剂的研究进展[J].沈阳药科大学学报,2004,21(4):314-320.
作者姓名:熊绪琼  赵冬梅  程卯生
作者单位:沈阳药科大学制药工程学院,辽宁,沈阳,110016
摘    要:目的阐述胆固醇酯转运蛋白 (CETP)抑制剂的研究新进展。方法对近年来国内外相关文献进行整理归纳。结果与结论CETP在协调血脂水平中发挥着重要的作用 ,它与冠心病 (CHD)的发生和发展密切相关 ,可能成为治疗CHD的一个潜在的新靶标 ,因此其抑制剂的研发具有广阔的应用前景。

关 键 词:胆固醇酯转运蛋白  冠心病  抑制剂
文章编号:1006-2858(2004)04-0314-07

Progress in the study of the cholesteryl ester transfer protein inhibitors
XIONG Xu-qiong,ZHAO Dong-mei,CHENG Mao-sheng.Progress in the study of the cholesteryl ester transfer protein inhibitors[J].Journal of Shenyang Pharmaceutical University,2004,21(4):314-320.
Authors:XIONG Xu-qiong  ZHAO Dong-mei  CHENG Mao-sheng
Abstract:Objective To review the recent progress in the inhibitors of the cholesteryl ester transfer protein (CETP).Method To sum up several recent references and 11 patents which are related with CETP.Results and Conclusion CETP may be regarded as a potentially atherogenic factor,which mediates the exchange of cholesteryl ester (CE) from the high-density lipoprotein (HDL) for triglyceride (TG) in the low density lipoprotein (LDL).The process decreases the level of anti-atherogenic HDL cholesterol and increases pro-atherogenic LDL.The inhibition of the activity of CETP thus represents a potential new therapeutic approach to treat coronary heart disease (CHD).
Keywords:cholesteryl ester transfer protein  coronary heart disease  inhibitors
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号